Clinical Trial Update: The Pharmacodynamics of Doripenem Between 4-hour and 1-hour Infusion in Patients With Ventilator-associated Pneumonia [Phase 4]

View source ↗

Summary

Phase 4 pharmacodynamics study evaluating 4-hour versus 1-hour infusion of doripenem in patients with ventilator-associated pneumonia to compare drug exposure a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ventilator-associated Pneumonia

Drugs mentioned

• Doripenem (Doripenem)

Snippet

Sponsor: Sutep Jaruratanasirikul | Conditions: Ventilator-Associated Pneumonia | Phase 4 | Status: COMPLETED